Skip to main content
Livermore
Livermore
ZHEN

LSV Asset Management

SEC CIK
0001050470
Latest filing
Aug 6, 2026

IRWD holding history

Ironwood Pharmaceuticals Inc in every 13F filed by LSV Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IRWD overviewAll 13F holders of IRWDFull Q2 2026 holdings

Shares (Q2 2026)
308,271
Value
$1.30M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of IRWD by LSV Asset Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026308,271$1.30M<0.1%00.0%UnchangedHolders
Q1 2026308,271$1.08M<0.1%+299,223+3,307.1%AddedHolders
Q4 20259,048$30.0K<0.1%+9,048NewHolders
Q3 20250$00.0%−2,750,200−100.0%Sold outHolders
Q2 20252,750,200$1.97M<0.1%−1,247,601−31.2%ReducedHolders
Q1 20253,997,801$5.88M<0.1%−83,700−2.1%ReducedHolders
Q4 20244,081,501$18.1M<0.1%−970,100−19.2%ReducedHolders
Q3 20245,051,601$20.8M<0.1%−1,019,900−16.8%ReducedHolders
Q2 20246,071,501$39.6M0.1%−79,500−1.3%ReducedHolders
Q1 20246,151,001$53.6M0.1%−631,100−9.3%ReducedHolders
Q4 20236,782,101$77.6M0.2%−382,108−5.3%ReducedHolders
Q3 20237,164,209$69.0M0.2%−506,100−6.6%ReducedHolders
Q2 20237,670,309$81.6M0.2%+92,600+1.2%AddedHolders
Q1 20237,577,709$79.7M0.2%−348,688−4.4%ReducedHolders
Q4 20227,926,397$98.2M0.2%+12,177+0.2%AddedHolders
Q3 20227,914,220$82.0M0.2%+435,063+5.8%AddedHolders
Q2 20227,479,157$86.2M0.2%+71,827+1.0%AddedHolders
Q1 20227,407,330$93.2M0.2%−100,076−1.3%ReducedHolders
Q4 20217,507,406$87.5M0.2%−304,821−3.9%ReducedHolders
Q3 20217,812,227$102.0M0.2%+3,448,000+79.0%AddedHolders
Q2 20214,364,227$56.2M0.1%+3,390,228+348.1%AddedHolders
Q1 2021973,999$10.9M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.